Michael Peter Hahn

Title: Michael Peter Hahn: Innovator in Pharmaceutical Chemistry

Introduction

Michael Peter Hahn is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for rare diseases. His work focuses on innovative compounds that can improve patient outcomes.

Latest Patents

One of Michael Peter Hahn's key patents is related to isofagomine salts, methods of use, and formulations. This invention pertains to isofagomine (IFG) and novel salts thereof, along with preparation methods and their applications in formulating pharmaceutical compositions for the treatment of Gaucher disease. The patent also includes novel crystalline forms of isofagomine salts, methods for preparing these forms, and their use in pharmaceutical compositions.

Career Highlights

Michael Peter Hahn is associated with Takeda Pharmaceutical Company Limited, where he has been instrumental in advancing pharmaceutical research and development. His expertise in pharmaceutical chemistry has led to innovative solutions that address unmet medical needs.

Collaborations

Throughout his career, Michael has collaborated with esteemed colleagues, including Helge Alfred Reisch and Jeffrey Scott DePue. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical solutions.

Conclusion

Michael Peter Hahn's contributions to pharmaceutical innovation, particularly in the treatment of Gaucher disease, highlight his role as a leading inventor in the field. His work continues to impact the lives of patients and advance the pharmaceutical industry.